Early Antiretroviral Therapy Reduces Severity but Does Not Eliminate Neurodevelopmental Compromise in Children With

Sarah Benki-Nugent1, Nancy Tamasha2, Alice Mueni2

  • 1Department of Global Health, University of Washington, Seattle.

Insights

Starting antiretroviral therapy (ART) in infancy for children with HIV attenuates neurodevelopmental deficits but does not fully eliminate them. Early ART improves cognitive and motor outcomes compared to late ART, though some impairments persist compared to HIV-unexposed children.

Area of Science:

  • Pediatric Infectious Diseases
  • Neurodevelopmental Disorders
  • HIV/AIDS Research

Background:

  • Human Immunodeficiency Virus (HIV) infection in children can lead to neurodevelopmental impairments.
  • Early initiation of antiretroviral therapy (ART) is crucial for managing HIV in infants.
  • The precise extent of cognitive benefits from early ART in pediatric HIV is not fully understood.

Purpose of the Study:

  • To evaluate the long-term neurodevelopmental outcomes in children with HIV who received early ART versus late ART.
  • To compare the cognitive, behavioral, and motor outcomes of children with HIV (early and late ART) against HIV-unexposed uninfected children (CHUU).

Main Methods:

  • Cognitive, behavioral, and motor assessments were conducted in three groups: children with HIV and early ART (<1 year), children with HIV and late ART (1.5-6 years), and CHUU.
  • Domain z scores and odds of neurobehavioral impairment were compared using adjusted analyses.
  • Participants were recruited from HIV care centers in Nairobi, Kenya.

Main Results:

  • Children receiving late ART showed significantly poorer outcomes across multiple cognitive, learning, and motor domains compared to those receiving early ART.
  • Children receiving early ART still exhibited lower cognitive and behavioral regulation scores compared to CHUU, indicating persistent neurodevelopmental compromise.
  • Children receiving late ART had the most significant deficits across nearly all assessed domains compared to CHUU.

Conclusions:

  • Initiating ART within the first year of life significantly mitigates but does not entirely prevent the neurodevelopmental consequences of HIV infection in children.
  • While early ART improves outcomes, ongoing monitoring and support are necessary for children with HIV to address residual neurodevelopmental challenges.
Abstract

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.4K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.1K
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.6K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
237
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
140